BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 96 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $8,449,000 | +31.7% | 151,685 | +8.0% | 0.00% | 0.0% |
| Q3 2016 | $6,416,000 | +12.2% | 140,493 | -1.9% | 0.00% | 0.0% |
| Q2 2016 | $5,720,000 | +25.8% | 143,214 | +9.6% | 0.00% | 0.0% |
| Q1 2016 | $4,548,000 | -18.3% | 130,614 | +0.8% | 0.00% | 0.0% |
| Q4 2015 | $5,569,000 | -17.9% | 129,591 | -16.8% | 0.00% | 0.0% |
| Q3 2015 | $6,780,000 | +38.0% | 155,726 | +63.5% | 0.00% | 0.0% |
| Q2 2015 | $4,914,000 | +35.3% | 95,235 | +2.7% | 0.00% | 0.0% |
| Q1 2015 | $3,632,000 | -5.1% | 92,762 | -6.4% | 0.00% | 0.0% |
| Q4 2014 | $3,829,000 | +35.3% | 99,157 | +23.7% | 0.00% | – |
| Q3 2014 | $2,830,000 | +30.2% | 80,161 | -0.6% | 0.00% | – |
| Q2 2014 | $2,174,000 | +16.4% | 80,629 | +12.0% | 0.00% | – |
| Q1 2014 | $1,867,000 | +1089.2% | 72,013 | +894.5% | 0.00% | – |
| Q4 2013 | $157,000 | +234.0% | 7,241 | +200.8% | 0.00% | – |
| Q3 2013 | $47,000 | +2.2% | 2,407 | -18.0% | 0.00% | – |
| Q2 2013 | $46,000 | – | 2,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |